Subgroup analyses of the PHOTON trial show visual acuity gains across subgroups by race, baseline visual acuity and retina ...

Stephanie Graff, M.D., FACP, FASCO, director of breast oncology at the Lifespan Cancer Institute and author of Investigating the Salience of Clinical Meaningfulness and Clinically Meaningful Outcomes ...

University of Washington’s Peter Rabinowitz, M.D., M.P.H.. sees a world awash in emerging diseases and climate change data ...

Health plans and PBMs are using AI to aggregate data, summarize information and enhance their formulary decision-making ...

The list includes dengue fever, chikungunya, leptospirosis and Valley fever, says University of Washington professor Peter ...

Technology can help address the complexities of specialty medications by automating processes and enabling proactive interventions to ensure patients stay on their critical therapies, according to ...

Clinical and other trials for GLP-1 therapies have found an association between these drugs and diabetic retinopathy ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Up to half of patients showed significant improvement in study results presented at the American Academy of Ophthalmology ...

Data about higher doses that are injected less often come as the original 2-milligram dose of Eylea is facing an increasing ...

In the threat versus opportunity session, Cecilia and Aaron Lee of the University of Washington staked out opposing positions ...

Rapid weight loss from the glucagon-like peptide 1 (GLP-1s) can reduce fat tissue in face that makes for a smooth, more ...